
|Videos|November 9, 2014
Reaction to Next-Generation Pharmacistâ„¢ Civic Leader of the Year Selection
Danny R. Johnson, RPh, recounts how he reacted to being selected as a finalist for the Next-Generation Pharmacistâ„¢ Civic Leader of the Year award.
Advertisement
Danny R. Johnson, RPh, recounts how he reacted to being selected as a finalist for the Next-Generation Pharmacist™ Civic Leader of the Year award.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy
2
Study: Many Patients Switching Biologics Because of Perceived Lack of Efficacy Treating Asthma
3
FDA Approves Targeted Combination Therapy for BRCA2-Mutated Prostate Cancer
4
Targeted ADCs Break Through Barriers in HER2-Positive Breast Cancer
5

















































































































































































































